Your browser doesn't support javascript.
loading
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.
Bachy, Emmanuel; Seymour, John F; Feugier, Pierre; Offner, Fritz; López-Guillermo, Armando; Belada, David; Xerri, Luc; Catalano, John V; Brice, Pauline; Lemonnier, François; Martin, Alejandro; Casasnovas, Olivier; Pedersen, Lars M; Dorvaux, Véronique; Simpson, David; Leppa, Sirpa; Gabarre, Jean; da Silva, Maria G; Glaisner, Sylvie; Ysebaert, Loic; Vekhoff, Anne; Intragumtornchai, Tanin; Le Gouill, Steven; Lister, Andrew; Estell, Jane A; Milone, Gustavo; Sonet, Anne; Farhi, Jonathan; Zeuner, Harald; Tilly, Hervé; Salles, Gilles.
Afiliação
  • Bachy E; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Institut National de la Santé et de la Recherche Médicale (INSERM) 1052, Pierre-Bénite, France.
  • Seymour JF; Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia.
  • Feugier P; Centre Hospitalier Régional Universitaire de Nancy, Université de Lorraine, INSERM 1256, Nancy, France.
  • Offner F; Ghent University, Ghent, Belgium.
  • López-Guillermo A; Hospital Clinic, Barcelona, Spain.
  • Belada D; Charles University, Hradec Králové, Czech Republic.
  • Xerri L; Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
  • Catalano JV; Frankston Hospital and Monash University, Frankston, Victoria, Australia.
  • Brice P; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Lemonnier F; Hôpitaux Universitaires Henri Mondor, Université Paris-Est Créteil, INSERM U955, Créteil, France.
  • Martin A; Hospital Universitario de Salamanca-Institute for Biomedical Research of Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Salamanca, Spain.
  • Casasnovas O; Department of Haematology and INSERM 1231, University Hospital F. Mitterrand, Dijon, France.
  • Pedersen LM; Herlev University Hospital, Copenhagen, Denmark.
  • Dorvaux V; Hôpital de Mercy Centre Hospitalier Régional Metz-Thionville, Metz, France.
  • Simpson D; North Shore Hospital, Auckland, New Zealand.
  • Leppa S; Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Gabarre J; Hôpital Pitié-Salpêtrière, Paris, France.
  • da Silva MG; Portuguese Institute of Oncology, Lisbon, Portugal.
  • Glaisner S; Institut Curie-Hôpital Rene Huguenin, Saint-Cloud, France.
  • Ysebaert L; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Vekhoff A; Saint Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Intragumtornchai T; Chulalongkorn University, Bangkok, Thailand.
  • Le Gouill S; Centre Hospitalier Universitaire de Nantes, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, INSERM, Université de Nantes, Nantes, France.
  • Lister A; Queen Mary University of London, London, United Kingdom.
  • Estell JA; Concord Hospital, Concord, University of Sydney, New South Wales, Australia.
  • Milone G; Fundaleu, Buenos Aires, Argentina.
  • Sonet A; UCL, Mont-Godinne, Yvoir, Belgium.
  • Farhi J; Centre Hospitalier Universitaire d'Angers, Angers, France.
  • Zeuner H; F Hoffman-La Roche, Basel, Switzerland.
  • Tilly H; Centre Henri-Becquerel, Rouen, France.
  • Salles G; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Institut National de la Santé et de la Recherche Médicale (INSERM) 1052, Pierre-Bénite, France.
J Clin Oncol ; 37(31): 2815-2824, 2019 11 01.
Article em En | MEDLINE | ID: mdl-31339826

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Conduta Expectante / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Conduta Expectante / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França